Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
Critical Care Medicine|October 1, 2009
Continuous lateral rotation therapy to prevent ventilator-associated pneumoniaThomas Staudinger, Andja Bojic, Ulrike Holzinger, et al.
BMC Cancer|March 28, 2006
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatmentRupert Bartsch, Catharina Wenzel, Ursula Pluschnig, et al.
Wiener Klinische Wochenschrift|January 1, 1996
[Results of critical care management of patients after bone marrow transplantation]A Wagner, T Staudinger, J Kofler, et al.
Critical Care Medicine|June 2, 2000
Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unitT Staudinger, B Stoiser, M Müllner, et al.
Leukemia & Lymphoma|August 9, 2005
Respiratory failure after stem cell transplantation: improved outcome with non-invasive ventilationWerner Rabitsch, Thomas Staudinger, Gottfried J Locker, et al.
The International Journal of Artificial Organs|November 4, 2014
Influence of different oxygenator types on changing frequency, infection incidence, and mortality in ARDS patients on veno-venous ECMOOliver Robak, Philipp K S Lakatos, Andja Bojic, et al.
ESMO Open|August 2, 2017
The European Society for Medical Oncology 'Magnitude of Clinical Benefit Scale' field-tested in infrequent tumour entities: an extended analysis of its feasibility at the Medical University of ViennaBarbara Kiesewetter, Markus Raderer, Gerald W Prager, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 2, 2004
Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosageB Meyer, F Traunmüller, A Hamwi, et al.
Cancer Immunology, Immunotherapy : CII|September 22, 2000
Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial. Austrian Renal Cell Carcinoma Study GroupM Schmidinger, G G Steger, C Wenzel, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1999
Continuous infusion versus intermittent administration of meropenem in critically ill patientsF Thalhammer, F Traunmüller, I El Menyawi, et al.
Pageof 18